Search results
Treatment-Resistant Depression Treatment Market is expected to expand at a CAGR of 9.0%, to reach a
PharmiWeb· 12 hours agoThere’s promising news for those struggling with Treatment-Resistant Depression Treatment Market for these specialized therapies is projected to reach a significant USD 4.0 billion by 2033, ...
The Spelthorne General Election candidates vying to get your vote
Surrey Live via Yahoo News UK· 4 days agoHis exceptional interest in local, national and Geopolitical interest led him to join the Green...
LONDON BRIEFING: Mixed bag for Astra drug; Landsec ups Bluewater stake
Morningstar· 6 days ago"One question that everyone asks is whether last week's good news marked the finale of the Nvidia's surge to the top, and if the past three-day selloff is the beginning of a sharper downside ...
London pre-open: Stocks to edge up after mixed US session
ShareCast· 6 days agoLondon stocks were set to nudge up at the open on Tuesday following a mixed close on Wall Street.
Your Voice, Your Vote: 'We need Covid drug Evusheld on the NHS'
BBC News· 3 days agoThe impact of Covid-19 on immunocompromised people is of major concern for an East Yorkshire...
'Challenging situation for hospitals' as Covid cases rise | ITV News
ITV.com· 3 days agoThere have been several outbreaks of Covid in wards across Cumbria, including the Cumberland...
I’d buy these investment trusts when interest rates fall
Fool.co.uk via Yahoo Finance UK· 2 days agoWant to move from a Cash ISA to a Stocks and Shares ISA, but with an eye on risk? Investment trusts...
Stocks tread water ahead of US inflation data
The Irish Times· 4 days agoEuropean stocks fell on Thursday as traders were cautious in advance of key inflation data and a fall in semiconductor stocks. US Treasury yields,...
I'd buy these investment trusts when interest rates fall
Motley Fool UK· 2 days agoWant to move from a Cash ISA to a Stocks and Shares ISA, but with an eye on risk? Investment trusts...
Health Care Roundup: Market Talk
The Wall Street Journal· 6 days agoFind insight on Rigel Pharmaceuticals, AstraZeneca, Merck KGaA and more in the latest Market Talks covering the Health Care sector.